Brown & Brown drops 3% as fresh analyst target cuts compound organic-growth worries
Brown & Brown shares fell about 3% to roughly $65 after a cluster of analyst price-target cuts this week, including JPMorgan lowering its target to $85 from $91. The stock has been sliding since the company’s late-January Q4 report highlighted weaker organic revenue trends despite higher adjusted profit.
1) What’s moving the stock today
Brown & Brown (BRO) traded lower by about 3% in the latest session, pressured by fresh sell-side recalibrations that reduced near-term upside expectations. JPMorgan lowered its price target to $85 from $91 while keeping a Neutral rating, adding to a run of recent target reductions that has weighed on sentiment toward insurance brokers and intermediaries. (streetinsider.com)
2) Why targets are coming down now
The latest cuts follow a period of heightened investor sensitivity to growth quality, with Brown & Brown’s recent results and outlook debate centered on whether acquisition-driven expansion can offset softer underlying organic performance. The company’s Q4 earnings season reaction underscored that point: despite higher adjusted profit, investors focused on slowing organic revenue trends, which helped push the shares down materially on the day of the report. (investing.com)
3) What to watch next
Investors will be watching for any incremental fundamentals that either stabilize the organic growth narrative or confirm continued pressure, including additional analyst revisions and any new company updates via SEC filings. Brown & Brown’s investor relations site shows an April 9, 2026 Form 8-K filing was posted, which market participants may review for any incremental details even if today’s move appears primarily sentiment/ratings driven. (investor.bbrown.com)